![]() |
|
|
-METHYL-META-TYROSINE
1 Laboratory of Clinical Biochemistry, National Heart Institute, National Institutes of Health, Bethesda, Maryland
It has been shown that
-methyl-meta-tyrosine (
-MMT) must be decarboxylated in order to bring about release of norepinephrine from tissues.
-Methyl-meta-tyramine and aramine, metabolic products of
-MMT, are even more potent with respect to norepinephrine releasing activity. Thus
-MMT, and no doubt
-methyl-dopa, represent unique ways of administering the corresponding pharmacologically active amines. Far less than stoichiometric amounts of the
-methyl-meta-tyramines are required to bring about and maintain depletion of norepinephrine.
This article has been cited by other articles:
![]() |
J. R. Crout, H. S. Alpers, E. L. Tatum, and P. A. Shore Release of Metaraminol (Aramine) from the Heart by Sympathetic Nerve Stimulation Science, August 21, 1964; 145(3634): 828 - 829. [Abstract] [PDF] |
||||
![]() |
J. N. Hingtgen and M. H. Aprison Behavioral Response Rates in Pigeons: Effect of agr-Methyl-m-tyrosine Science, July 12, 1963; 141(3576): 169 - 171. [Abstract] [PDF] |
||||